(Q54395791)

29 May 2018

title

Effects of cyclosporine in severe systemic lupus erythematosus. (English)

1 reference

29 May 2018

systemic lupus erythematosus

1 reference

0 references

author name string

Feutren G

1

1 reference

29 May 2018

Querin S

2

1 reference

29 May 2018

Noël LH

3

1 reference

29 May 2018

Chatenoud L

4

1 reference

29 May 2018

Beaurain G

5

1 reference

29 May 2018

Tron F

6

1 reference

29 May 2018

Lesavre P

7

1 reference

29 May 2018

Bach JF

8

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 December 1987

1 reference

29 May 2018

The Journal of Pediatrics

published in

1 reference

29 May 2018

volume

111

1 reference

29 May 2018

issue

6 Pt 2

1 reference

29 May 2018

page(s)

1063-1068

1 reference

29 May 2018

Effect of treatment on the evolution of renal abnormalities in lupus nephritis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Drug therapy. Immunosuppressive agents. I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Treatment of intractable lupus nephritis with total lymphoid irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Total lymphoid irradiation in refractory systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

The 1982 revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Development of an immunochemical test to assess C1 inactivator function in human serum and its use for the diagnosis of hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

The differentiation and function of human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Cyclosporine-associated chronic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Cyclosporin relieves arthralgia, causes angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Effect of cyclosporin A on spontaneous autoimmune thyroiditis of Obese strain (OS) chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

Effects of cyclosporin on bullous pemphigoid and pemphigus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980057-4

10.1016/S0022-3476(87)80057-4

7 January 2021

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

3681569

1 reference

29 May 2018